Who owns INVIVO THERAPEUTICS HLDGS CO?
- Ticker: NVIVQ
- CUSIP Number: 46186m605
Tip: Access positions for across all investors
Analyze quarterly positions in Invivo Therapeutics Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Invivo Therapeutics Hldgs stock
Who bought or sold INVIVO THERAPEUTICS HLDGS CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Goldman Sachs Group | 24k | $5.2k | 100% | Mar 2024 |
|
| Barclays | 2.00 | $0 | 100% | Mar 2024 |
|
| Vima | 2.00 | $2.000000 | 0% | Mar 2024 |
|
| Sugarloaf Wealth Management | 1.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Invivo Therapeutics Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Sep 2023 | 35k | $35k |
| Vanguard Group | Dec 2023 | 31k | $23k |
| Geode Capital Management | Sep 2023 | 19k | $22k |
| Tower Research Capital | Sep 2023 | 7.6k | $8.5k |
| Morgan Stanley | Sep 2023 | 270.00 | $302.859000 |
| Wells Fargo & Company | Dec 2023 | 24.00 | $18.000000 |
| Advisor Group Holdings | Dec 2023 | 5.00 | $3.000000 |
| Indiana Trust & Investment Management | Dec 2023 | 2.00 | $1.000000 |
| UBS Group | Dec 2023 | 1.00 | $1.000000 |
| Hanson McClain Advisors | Dec 2023 | 1.00 | $1.000000 |
| Milestone Investment Advisors | Sep 2023 | 1.00 | $2.000000 |